Ipamorelin is a synthetic hexapeptide that mimics the natural growth hormone releasing hormone (GHRH). When supplied at a 10 mg dose, it provides a robust stimulus for the pituitary gland to secrete endogenous growth hormone without the excessive prolactin or cortisol release often seen with other analogues. The 10 mg strength is favored by both research laboratories and athletes who require precise dosing to balance anabolic benefits against potential side effects.
**Ipamorelin Peptide Information**
This peptide consists of six amino acids: N-terminal pyroglutamic acid, phenylalanine, leucine, alanine, glycine, and a C-terminal amide. Its primary action is selective activation of the GHRH receptor subtype 1A (GHRH-R1A). Unlike older growth hormone secretagogues such as GHRP-2 or GHRP-6, Ipamorelin’s selectivity results in minimal stimulation of prolactin and cortisol pathways. Pharmacokinetically, it has a short half-life (~20 minutes), requiring multiple daily injections for sustained effect.
**FORM**
Ipamorelin is typically supplied as a sterile aqueous solution or lyophilized powder that can be reconstituted with bacteriostatic water to achieve the desired concentration. The final product should be clear, colorless, and free of particulate matter.
**CAS NUMBER**
The International Union of Pure and Applied Chemistry (IUPAC) assigns Ipamorelin the CAS registry number 156411-41-5. This unique identifier ensures traceability across suppliers and regulatory databases.
**OTHER NAMES**
Ipamorelin is also marketed under several proprietary names such as "IGF-1 Mimetics," “Growth Hormone Secretagogue 3,” or simply “GHRP-4” in certain research circles. It may appear in combination with other peptides in multi-peptide kits.
**WEIGHT**
In the context of peptide synthesis, weight refers to both the molecular mass and the powder yield per vial. A typical 10 mg vial contains a total of approximately 10 000 µg of pure peptide, which translates to roughly 4–5 mL of reconstituted solution at a 1 mg/mL concentration.
**SEQUENCE**
The amino acid sequence is: Phe-Leu-Ala-Gly-N-terminal pyroglutamic acid (pGlu) – amide. This compact arrangement confers resistance to proteolytic enzymes and improves stability in physiological conditions.
**Molecular Weight**
The calculated molecular weight of Ipamorelin is 1 042 Da. This figure is used for dosing calculations, purity assessments, and analytical chromatography profiling.
**Terms**
Key terms associated with Ipamorelin include: growth hormone secretagogue, anabolic peptide, selective GHRH receptor agonist, short-acting peptide, and minimal endocrine side effects. Understanding these terms helps researchers differentiate Ipamorelin from other growth hormone stimulants.
**Why isn’t there more information on Ipamorelin?**
Ipamorelin’s relatively recent development and its primary use in research rather than clinical therapy mean that comprehensive human trials are limited. Regulatory restrictions on peptide research, coupled with a focus on animal studies for safety profiling, contribute to the scarcity of publicly available data. Additionally, many studies keep detailed pharmacodynamic results confidential due to commercial interests.
**The Standard of Excellence**
Our supply chain adheres to rigorous quality control standards to guarantee that every batch meets or exceeds industry benchmarks. Each lot undergoes independent testing for purity, potency, and safety before reaching the end user.
**Our Peptides Are Tested For:**
- **Purity** – Confirmed via high-performance liquid chromatography (HPLC) with a purity threshold of ≥ 98 %.
- **Weight** – Weighing each vial against certified reference materials ensures accurate dosing.
- **Endotoxins (LPS)** – Limulus amebocyte lysate (LAL) assays confirm endotoxin levels are below the permissible limit for injectable peptides.
Our peptides are also verified for:
- **Exploring Other High-Purity Peptides** – We offer a range of research-grade peptides, each meeting identical quality criteria.
**BPC-157 Peptide (10MG)**
BPC-157 is a synthetic peptide derived from body protection compound, known for its wound healing and anti-inflammatory properties. The 10 mg dosage supports rapid tissue repair in preclinical models.
**Blend: BPC-157 TB-500 Peptide (20MG)**
Combining BPC-157 with TB-500, a thymosin beta-4 analogue, yields synergistic effects on angiogenesis and muscle regeneration. The 20 mg blend is tailored for researchers studying complex healing pathways.
**TB-500 Peptide (TB 10MG)**
TB-500 promotes cell migration, collagen production, and vascular remodeling. At 10 mg, it provides a potent stimulus for soft tissue repair without systemic toxicity.
**GHK-Cu Copper Peptide 100MG**
GHK-Cu is a tripeptide that complexes with copper to modulate extracellular matrix synthesis, stimulate fibroblast proliferation, and enhance collagen deposition. The 100 mg concentration is ideal for dermatological research into anti-aging mechanisms.
**CJC-1295 DAC Peptide (5MG)**
This long-acting growth hormone releasing hormone analogue features a drug affinity complex that prolongs its half-life to several days. A 5 mg dose supports sustained growth hormone release for chronic studies.
**AOD-9604 Peptide (2.5MG)**
AOD-9604 is a truncated form of human growth hormone, engineered to preferentially stimulate lipolysis. The 2.5 mg formulation allows precise modulation of adipose tissue metabolism in experimental settings.
**NAD+ Peptide (1000MG)**
Although NAD⁺ itself is not a peptide, this product contains a precursor that enhances cellular nicotinamide adenine dinucleotide levels. At 1 000 mg, it supports studies on mitochondrial function and metabolic health.
These products collectively provide researchers with a versatile toolkit for investigating growth hormone pathways, tissue repair mechanisms, and metabolic regulation while maintaining stringent quality and safety standards.
**Ipamorelin Peptide (10MG)**
Ipamorelin is a synthetic hexapeptide that mimics the natural growth hormone releasing hormone (GHRH). When supplied at a 10 mg dose, it provides a robust stimulus for the pituitary gland to secrete endogenous growth hormone without the excessive prolactin or cortisol release often seen with other analogues. The 10 mg strength is favored by both research laboratories and athletes who require precise dosing to balance anabolic benefits against potential side effects.
**Ipamorelin Peptide Information**
This peptide consists of six amino acids: N-terminal pyroglutamic acid, phenylalanine, leucine, alanine, glycine, and a C-terminal amide. Its primary action is selective activation of the GHRH receptor subtype 1A (GHRH-R1A). Unlike older growth hormone secretagogues such as GHRP-2 or GHRP-6, Ipamorelin’s selectivity results in minimal stimulation of prolactin and cortisol pathways. Pharmacokinetically, it has a short half-life (~20 minutes), requiring multiple daily injections for sustained effect.
**FORM**
Ipamorelin is typically supplied as a sterile aqueous solution or lyophilized powder that can be reconstituted with bacteriostatic water to achieve the desired concentration. The final product should be clear, colorless, and free of particulate matter.
**CAS NUMBER**
The International Union of Pure and Applied Chemistry (IUPAC) assigns Ipamorelin the CAS registry number 156411-41-5. This unique identifier ensures traceability across suppliers and regulatory databases.
**OTHER NAMES**
Ipamorelin is also marketed under several proprietary names such as "IGF-1 Mimetics," “Growth Hormone Secretagogue 3,” or simply “GHRP-4” in certain research circles. It may appear in combination with other peptides in multi-peptide kits.
**WEIGHT**
In the context of peptide synthesis, weight refers to both the molecular mass and the powder yield per vial. A typical 10 mg vial contains a total of approximately 10 000 µg of pure peptide, which translates to roughly 4–5 mL of reconstituted solution at a 1 mg/mL concentration.
**SEQUENCE**
The amino acid sequence is: Phe-Leu-Ala-Gly-N-terminal pyroglutamic acid (pGlu) – amide. This compact arrangement confers resistance to proteolytic enzymes and improves stability in physiological conditions.
**Molecular Weight**
The calculated molecular weight of Ipamorelin is 1 042 Da. This figure is used for dosing calculations, purity assessments, and analytical chromatography profiling.
**Terms**
Key terms associated with Ipamorelin include: growth hormone secretagogue, anabolic peptide, selective GHRH receptor agonist, short-acting peptide, and minimal endocrine side effects. Understanding these terms helps researchers differentiate Ipamorelin from other growth hormone stimulants.
**Why isn’t there more information on Ipamorelin?**
Ipamorelin’s relatively recent development and its primary use in research rather than clinical therapy mean that comprehensive human trials are limited. Regulatory restrictions on peptide research, coupled with a focus on animal studies for safety profiling, contribute to the scarcity of publicly available data. Additionally, many studies keep detailed pharmacodynamic results confidential due to commercial interests.
**The Standard of Excellence**
Our supply chain adheres to rigorous quality control standards to guarantee that every batch meets or exceeds industry benchmarks. Each lot undergoes independent testing for purity, potency, and safety before reaching the end user.
**Our Peptides Are Tested For:**
- **Purity** – Confirmed via high-performance liquid chromatography (HPLC) with a purity threshold of ≥ 98 %.
- **Weight** – Weighing each vial against certified reference materials ensures accurate dosing.
- **Sterility** – Sterile filtration and aseptic processing eliminate microbial contamination.
- **Endotoxins (LPS)** – Limulus amebocyte lysate (LAL) assays confirm endotoxin levels are below the permissible limit for injectable peptides.
Our peptides are also verified for:
- **Exploring Other High-Purity Peptides** – We offer a range of research-grade peptides, each meeting identical quality criteria.
**BPC-157 Peptide (10MG)**
BPC-157 is a synthetic peptide derived from body protection compound, known for its wound healing and anti-inflammatory properties. The 10 mg dosage supports rapid tissue repair in preclinical models.
**Blend: BPC-157 TB-500 Peptide (20MG)**
Combining BPC-157 with TB-500, a thymosin beta-4 analogue, yields synergistic effects on angiogenesis and muscle regeneration. The 20 mg blend is tailored for researchers studying complex healing pathways.
**TB-500 Peptide (TB 10MG)**
TB-500 promotes cell migration, collagen production, and vascular remodeling. At 10 mg, it provides a potent stimulus for soft tissue repair without systemic toxicity.
**GHK-Cu Copper Peptide 100MG**
GHK-Cu is a tripeptide that complexes with copper to modulate extracellular matrix synthesis, stimulate fibroblast proliferation, and enhance collagen deposition. The 100 mg concentration is ideal for dermatological research into anti-aging mechanisms.
**CJC-1295 DAC Peptide (5MG)**
This long-acting growth hormone releasing hormone analogue features a drug affinity complex that prolongs its half-life to several days. A 5 mg dose supports sustained growth hormone release for chronic studies.
**AOD-9604 Peptide (2.5MG)**
AOD-9604 is a truncated form of human growth hormone, engineered to preferentially stimulate lipolysis. The 2.5 mg formulation allows precise modulation of adipose tissue metabolism in experimental settings.
**NAD+ Peptide (1000MG)**
Although NAD⁺ itself is not a peptide, this product contains a precursor that enhances cellular nicotinamide adenine dinucleotide levels. At 1 000 mg, it supports studies on mitochondrial function and metabolic health.
These products collectively provide researchers with a versatile toolkit for investigating growth hormone pathways, tissue repair mechanisms, and metabolic regulation while maintaining stringent quality and safety standards.